PL2558465T3 - Trycykliczne pirydylo-winylo-pirole jako inhibitory receptora aktywowanego proteazą 1 (PAR1) - Google Patents
Trycykliczne pirydylo-winylo-pirole jako inhibitory receptora aktywowanego proteazą 1 (PAR1)Info
- Publication number
- PL2558465T3 PL2558465T3 PL11715496T PL11715496T PL2558465T3 PL 2558465 T3 PL2558465 T3 PL 2558465T3 PL 11715496 T PL11715496 T PL 11715496T PL 11715496 T PL11715496 T PL 11715496T PL 2558465 T3 PL2558465 T3 PL 2558465T3
- Authority
- PL
- Poland
- Prior art keywords
- pyroles
- vinyl
- tricyclic
- pyridyl
- par1 inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10305396 | 2010-04-16 | ||
| EP11715496.3A EP2558465B1 (de) | 2010-04-16 | 2011-04-14 | Trizyklische pyridyl-vinyl-pyrrole als par1-inhibitoren |
| PCT/EP2011/055965 WO2011128421A1 (de) | 2010-04-16 | 2011-04-14 | Trizyklische pyridyl-vinyl-pyrrole als par1-inhibitoren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2558465T3 true PL2558465T3 (pl) | 2015-05-29 |
Family
ID=42244954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11715496T PL2558465T3 (pl) | 2010-04-16 | 2011-04-14 | Trycykliczne pirydylo-winylo-pirole jako inhibitory receptora aktywowanego proteazą 1 (PAR1) |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8871798B2 (pl) |
| EP (1) | EP2558465B1 (pl) |
| ES (1) | ES2532902T3 (pl) |
| PL (1) | PL2558465T3 (pl) |
| WO (1) | WO2011128421A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3035929B1 (en) | 2013-08-22 | 2024-07-03 | Merck Sharp & Dohme LLC | 7a-amide substituted-6,6-difluoro bicyclic himbacine derivatives |
| WO2015026686A1 (en) | 2013-08-22 | 2015-02-26 | Merck Sharp & Dohme Corp. | 3'-pyridyl substituted- 6,6-difluoro bicyclic himbacine derivatives |
| WO2015026685A1 (en) | 2013-08-22 | 2015-02-26 | Merck Sharp & Dohme Corp. | 7a-heterocycle substituted- 6, 6-difluoro bicyclic himbacine derivatives |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063847A (en) | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
| PL195027B1 (pl) | 1997-11-25 | 2007-08-31 | Schering Corp | Tricykliczny związek, jego zastosowanie i zawierająca go kompozycja farmaceutyczna |
| US7488742B2 (en) | 2000-06-15 | 2009-02-10 | Schering Corporation | Thrombin receptor antagonists |
| US7235567B2 (en) | 2000-06-15 | 2007-06-26 | Schering Corporation | Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| ATE368659T1 (de) | 2000-06-15 | 2007-08-15 | Schering Corp | Thrombinrezeptorantagonisten |
| US20040192753A1 (en) | 2000-06-15 | 2004-09-30 | Samuel Chackalamannil | Methods of use of thrombin receptor antagonists |
| EP1614680B1 (en) | 2001-04-19 | 2011-12-21 | Eisai R&D Management Co., Ltd. | Process for preparing 2-iminopyrrolidine derivatives |
| US6956046B2 (en) | 2001-05-25 | 2005-10-18 | Mochida Pharmaceutical Co., Ltd. | 4-hydroxypiperidine derivatives having analgesic activity |
| EP1860106B1 (en) | 2002-04-16 | 2010-01-20 | Schering Corporation | Tricyclic thrombin receptor antagonists |
| EP1607436B2 (en) | 2003-03-25 | 2019-06-12 | Sekisui Plastics Co., Ltd. | Expandable resin beads of styrene-modified linear low-density polyethylene |
| DE602005009355D1 (de) | 2004-05-28 | 2008-10-09 | Schering Corp | Gehinderte himbacinanaloga als thrombinrezeptorantagonisten |
| EP2075250B1 (en) | 2004-10-08 | 2015-03-04 | Merck Sharp & Dohme Corp. | Thrombin receptor antagonists |
| EP1853592B1 (en) | 2005-01-14 | 2011-03-02 | Schering Corporation | Synthesis of himbacine analogs |
| WO2006105217A2 (en) | 2005-03-31 | 2006-10-05 | Schering Corporation | Spirocyclic thrombin receptor antagonists |
| CA2634907A1 (en) | 2005-12-22 | 2007-07-05 | Schering Corporation | Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| AR060095A1 (es) | 2006-03-29 | 2008-05-21 | Schering Corp | Derivados de himbacina monociclicos y biciclicos utiles como antogonistas de los receptores de trombina |
| US8153664B2 (en) | 2006-10-04 | 2012-04-10 | Schering Corporation | Bicyclic and tricyclic derivatives as thrombin receptor antagonists |
| WO2009124103A2 (en) | 2008-04-02 | 2009-10-08 | Schering Corporation | Combination therapies comprising par1 antagonists with par4 antagonists |
-
2011
- 2011-04-14 EP EP11715496.3A patent/EP2558465B1/de not_active Not-in-force
- 2011-04-14 PL PL11715496T patent/PL2558465T3/pl unknown
- 2011-04-14 WO PCT/EP2011/055965 patent/WO2011128421A1/de active Application Filing
- 2011-04-14 ES ES11715496.3T patent/ES2532902T3/es active Active
-
2012
- 2012-10-16 US US13/652,898 patent/US8871798B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011128421A1 (de) | 2011-10-20 |
| EP2558465A1 (de) | 2013-02-20 |
| EP2558465B1 (de) | 2014-12-17 |
| US8871798B2 (en) | 2014-10-28 |
| US20130040943A1 (en) | 2013-02-14 |
| ES2532902T3 (es) | 2015-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201002983D0 (en) | Nutritinal composition | |
| GB201006699D0 (en) | Composition | |
| GB201021186D0 (en) | Composition | |
| GB201006178D0 (en) | Composition | |
| AP3030A (en) | Propynylaminoindan transdermal compositions | |
| EP2625231A4 (en) | INK PRESERVATIVE COMPOSITIONS | |
| GB201021269D0 (en) | Composition | |
| GB201017048D0 (en) | Composition | |
| PL2625258T3 (pl) | Kompozycja do czyszczenia z polimerów | |
| GB201019988D0 (en) | Composition | |
| GB201016970D0 (en) | Composition | |
| GB201007531D0 (en) | Composition | |
| GB201006214D0 (en) | Composition | |
| PL2558465T3 (pl) | Trycykliczne pirydylo-winylo-pirole jako inhibitory receptora aktywowanego proteazą 1 (PAR1) | |
| ZA201303199B (en) | Herbicicdal composition | |
| GB201006204D0 (en) | Composition | |
| GB201004717D0 (en) | Composition | |
| GB201014967D0 (en) | Composition | |
| GB201010657D0 (en) | Composition | |
| GB201006175D0 (en) | Composition | |
| PL2558462T3 (pl) | Pirydylo-winylo-pirazolo-chinoliny jako inhibitory PAR1 | |
| PL2534235T3 (pl) | Kompozycja | |
| GB201018130D0 (en) | Composition | |
| GB201006182D0 (en) | Composition | |
| GB201006012D0 (en) | Composition |